Sunosi 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FN3UA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,015
Award facts
- Contract value 100% obligated
- $1,015.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count units) valued at $1,015.43 under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 13, 2025. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy and other sleep disorders. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems through DLA's Medical Supply Chain.
This delivery order represents a transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply requirements, including specialty medications, generic drugs, and medical devices across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FN3UA?
SPE2DB25FN3UA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FN3UA worth?
The government has obligated $1,015 on SPE2DB25FN3UA.
Is contract SPE2DB25FN3UA an order under another contract?
Yes. SPE2DB25FN3UA is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3UA competed?
The extent of competition for SPE2DB25FN3UA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award